PDCD1 and melanoma: OXPHOS metabolism of cancer cells is associated with T-cell exhaustion and poor response to Programmed cell death 1 (PD-1) blockade immunotherapy in melanoma due to high oxygen consumption resulting in hypoxia in the TME (34).